[1] |
JAMAL S M, BELSHAM G J. Foot-and-mouth disease:past, present and future[J]. Vet Res, 2013, 44(1):116.
|
[2] |
DOMINGO E, BARANOWSKI E, ESCARMIS C, et al. Foot-and-mouth disease virus[J]. Comp Immunol Microbiol Infect Dis, 2002, 25(5-6):297-308.
|
[3] |
GRUBMAN M J, BAXT B. Foot-and-mouth disease[J]. Clin Microbiol Rev, 2004, 17(2):465-493.
|
[4] |
GRUBMAN M J, MORAES M P, DIAZ-SAN SEGUNDO F, et al. Evading the host immune response:how foot-and-mouth disease virus has become an effective pathogen[J]. FEMS Immunol Med Microbiol, 2008, 53(1):8-17.
|
[5] |
李 显, 张富东, 张中旺, 等. 口蹄疫病毒利用自身蛋白逃逸宿主天然免疫应答的研究进展[J]. 畜牧兽医学报, 2020, 51(11):2622-2632.LI X, ZHANG F D, ZHANG Z W, et al. Recent advance on foot-and-mouth disease virus utilizes self-proteins to evade innate immunity response of host[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(11):2622-2632. (in Chinese)
|
[6] |
KENUBIH A. Foot and mouth disease vaccine development and challenges in inducing long-lasting immunity:trends and current perspectives[J]. Vet Med (Auckl), 2021, 12:205-215.
|
[7] |
YANG B, ZHANG X H, ZHANG D J, et al. Molecular mechanisms of immune escape for foot-and-mouth disease virus[J]. Pathogens, 2020, 9(9):729.
|
[8] |
RODRÍGUEZ-HABIBE I, CELIS-GIRALDO C, PATARROYO M E, et al. A comprehensive review of the immunological response against foot-and-mouth disease virus infection and its evasion mechanisms[J]. Vaccines (Basel), 2020, 8(4):764.
|
[9] |
ABUBAKAR M, MANZOOR S, AHMED A. Interplay of foot and mouth disease virus with cell-mediated and humoral immunity of host[J]. Rev Med Virol, 2018, 28(2):e1966.
|
[10] |
RAD F R, AJDARY S, OMRANIPOUR R, et al. Comparative analysis of CD4+ and CD8+ T cells in tumor tissues, lymph nodes and the peripheral blood from patients with breast cancer[J]. Iran Biomed J, 2015, 19(1):35-44.
|
[11] |
XIAO M L, CHEN X Y, HE R, et al. Differentiation and function of follicular CD8 T cells during human immunodeficiency virus infection[J]. Front Immunol, 2018, 9:1095.
|
[12] |
DIAZ-SAN SEGUNDO F, SALGUERO F J, DE AVILA A, et al. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine[J]. J Virol, 2006, 80(5):2369-2379.
|
[13] |
BAUTISTA E M, FERMAN G S, GOLDE W T. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV)[J]. Vet Immunol Immunopathol, 2003, 92(1-2):61-73.
|
[14] |
ROJAS J M, AVIA M, MARTÍN V, et al. IL-10:a multifunctional cytokine in viral infections[J]. J Immunol Res, 2017, 2017:6104054.
|
[15] |
DÍAZ-SAN SEGUNDO F, RODRÍGUEZ-CALVO T, DE AVILA A, et al. Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10[J]. PLoS One, 2009, 4(5):e5659.
|
[16] |
ZHANG Z D, DOEL C, BASHIRUDDIN J B. Interleukin-10 production at the early stage of infection with foot-and-mouth disease virus related to the likelihood of persistent infection in cattle[J]. Vet Res, 2015, 46:132.
|
[17] |
GUO Z J, ZHAO Y, ZHANG Z D, et al. Interleukin-10-mediated lymphopenia caused by acute infection with foot-and-mouth disease virus in mice[J]. Viruses, 2021, 13(12):2358.
|
[18] |
刘丹华, 郑世民, 刘晓静, 等. 禽网状内皮组织增生病病毒感染对SPF雏鸡血液和局部淋巴组织CD4+/CD8+细胞及相关细胞因子表达的影响[J]. 畜牧兽医学报, 2020, 51(6):1447-1454.LIU D H, ZHENG S M, LIU X J, et al. Effects of avian reticuloendotheliosis virus infection on the CD4+/CD8+ ratio and the expression of related cytokines in SPF chicks[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(6):1447-1454. (in Chinese)
|
[19] |
FAN Y, BAI H W, QIAN Y Y, et al. CD4+ T cell immune response to VP1 and VP3 in BK virus infected recipients of renal transplantation[J]. Surg Infect (Larchmt), 2019, 20(3):236-243.
|
[20] |
SHARAN R, SINGH D K, RENGARAJAN J, et al. Characterizing early T cell responses in nonhuman primate model of tuberculosis[J]. Front Immunol, 2021, 12:706723.
|
[21] |
SUN P, ZHANG S M, QIN X D, et al. Foot-and-mouth disease virus capsid protein VP2 activates the cellular EIF2S1-ATF4 pathway and induces autophagy via HSPB1[J]. Autophagy, 2018, 14(2):336-346.
|
[22] |
GIAMARELLOS-BOURBOULIS E J, NETEA M G, ROVINA N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure[J]. Cell Host Microbe, 2020, 27(6):992-1000. e3.
|
[23] |
PALANQUES-PASTOR T, LÓPEZ-BRIZ E, POVEDA ANDRéS J L. Involvement of interleukin 6 in SARS-CoV-2 infection:siltuximab as a therapeutic option against COVID-19[J]. Eur J Hosp Pharm, 2020, 27(5):297-298.
|
[24] |
POL J G, CAUDANA P, PAILLET J, et al. Effects of interleukin-2 in immunostimulation and immunosuppression[J]. J Exp Med, 2020, 217(1):e20191247.
|
[25] |
MEHTA A K, GRACIAS D T, CROFT M. TNF activity and T cells[J]. Cytokine, 2018, 101:14-18.
|
[26] |
BAXTER A G, HODGKIN P D. Activation rules:the two-signal theories of immune activation[J]. Nat Rev Immunol, 2002, 2(6):439-446.
|
[27] |
CHEN L P, FLIES D B. Molecular mechanisms of T cell co-stimulation and co-inhibition[J]. Nat Rev Immunol, 2013, 13(4):227-242.
|
[28] |
TAYLOR A, VERHAGEN J, BLASER K, et al. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β:the role of T regulatory cells[J]. Immunology, 2006, 117(4):433-442.
|
[29] |
JUBEL J M, BARBATI Z R, BURGER C, et al. The role of PD-1 in acute and chronic infection[J]. Front Immunol, 2020, 11:487.
|